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Abstract
The extracellular matrix (ECM) represents the framework of tissues and organs and is
involved in cell differentiation and function. The study of ECM is challenging and required
a combination of identification and imaging techniques to give a valuable scheme of its
composition, organization, and finally function. The study of ECM enables to culture cells
ex vivo, but cultures are restricted to two-dimensional surfaces, whereas in the mean‐
time, material sciences were developing devices able to bring cell culture in a three-
dimensional (3D) environment. This chapter presents basic techniques to investigate
extracellular  matrices  composition  and  organization.  Basic  knowledge  on  ECM
composition  and  organization  should  inspire  material  scientists  to  propose  more
biologically relevant materials. In a second time, we present strategies available to create
ex vivo models of ECM and a series of examples of 3D materials that were engineered to
investigate  cell  adhesion,  phenotype,  and differentiation  in  a  biologically  relevant
microenvironment. The production of a gold-standard material is possible for a specific
biological question, and it might be developed from an intelligible dialogue between
material scientists, that bring engineering strategies, and cell biologists who implement
the material design to meet the biological process that has to be investigated ex vivo.
Keywords: extracellular matrix, tissue organization, 3D materials, in vitro cell culture
models, tissue engineering
1. Introduction
Multicellular organisms require a framework to delineate functional territories and to pro‐
vide a shelf where the cells can attach to perform their specific functions. The extracellular matrix
(ECM) represents this framework for tissues and organs and as such it is an important actor of
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organisms’ physiology. The most known examples of ECM-related tissues are the skin, where
ECM act as a barrier against the outside environment, and the bones where ECM is strength‐
ened by a mineral phase which allows the body to stand and to move. However, its apparent
structural and mechanical properties have hidden more subtle roles of ECM in cell differentia‐
tion and function as ECMs are not restricted to load-bearing organs but are present and required
in all types of tissues and organs. During the development of the embryo, neural crest cells lose
their cell-cell adhesion properties toward cell–ECM interactions that allow them to move along
the dorsal part of the embryo and reach their specific site of function and give birth to the future
skeleton. Again, tissue remodeling, as observed during the healing processes, can release
messenger molecules that were entrapped in the ECM, waiting for the right moment to trigger
their signal and healing functions [1]. Some lack of knowledge on ECM functions remains mainly
because of the challenge represented by its comprehensive study. Indeed, ECM is made of several
high molecular weight proteins, proteoglycans, and polysaccharides molecules self-arranged
into fibers and networks difficult to solubilize and individualize. Basic biochemistry techni‐
ques have led to the identification of the major components of ECMs such as collagens or laminins,
but as the investigations are progressing, this results in the constant growing of the constitu‐
ent members of collagen and laminin families and in the discovery of new ECM components
with unknown functions [2]. Moreover, understanding the ECM not only means discovering
new molecules but also to unravel their organization in the ECM network. So the study of ECM
requires the combination of identification and imaging techniques to give a valuable scheme of
its composition, organization, and finally function. Interestingly, unraveling ECM complexity
meets one of the fundamental questions for biologists: how to recreate and maintain life outside
a living organism (literally ex vivo but commonly referred as in vitro)?
The beginning of the 20th century aroused the possibility to dissociate cells from living tissues
and to culture them ex vivo. This new technique has triggered the emergence of the new
discipline of cell biology which has brought most of the knowledge that we possess today on
cell proliferation, differentiation, metabolism, cell fate, and death. However, ex vivo cell
cultures were restricted to two-dimensional (2-D) culture systems, originally on glass and
subsequently on plastic dishes, occasionally supplemented by the coating of ECM molecules
to favor cell adhesion. Parallel to the development of cell biology, the broad field of materials
science was creating polymers and devices able to bring ex vivo cell culture to the third
dimension, and to the 21st century. Dedicated to materials that interact with living tissues, the
field of biomaterials encompasses several scientific disciplines, from physics and chemistry to
biochemistry and medicine. Several types of three-dimensional (3D) materials have been
engineered which may represent valuable tools for fundamental cell research, but a lack of
knowledge on ECM structures have undermined their use for cell biology. On the other hand,
cell biologists are not necessarily aware of the development and possibilities created by
extensive research in the field of 3D biomaterials, and this partly compromises the expansion
of 3D cell culture models.
In this chapter, we will present basic techniques involved in the investigation of extracellular
matrices and data generated by their use to understand ECM composition and organization.
Basic knowledge on ECM composition and organization should be useful for biomaterial
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scientists to propose more biologically relevant materials. Such methodologies are fully
transposable for the characterization of biomaterials and 3D models of ECMs. In a second
section, we will present a series of biomaterials that were engineered based on the investigation
of ECMs composition and organization in vivo and could become suitable 3D cell culture
models for mechanobiology, aging, cell migration, cell differentiation, and studies on
pathologies and their treatments.
2. Exploring the ECM
Extracellular matrices are multimolecular three-dimensional (3D) networks made of a large
variety of ECM-specific molecules and their compositions and organizations are tissue-
specific. Exploring the ECM means (1) the determination of its distribution within the tissue
and its relation to the cell content, (2) the identification and quantification of its composition,
and (3) the characterization of the 3-D architecture of the ECM network [2]. ECMs contain
similar biomolecules which can be organized in two main classes (1) proteins and glycopro‐
teins and (2) proteoglycans and polysaccharides. Variation in the composition or in the amount
of certain ECM molecules will change dramatically the physical properties of the ECM such
as the tensile strength observed in the hard mineralized ECM in bones, the elasticity observed
in dermis of the skin, or even the transparency in the cornea of the eye. The biochemistry of
ECM components strongly influences the techniques used to investigate them. Light micro‐
scopy associated with histological staining is based on the differences of biochemical features
of tissues (i.e., hydrophobicity, electrical charge, and molecular weight). Proteomics associated
with mass spectrometry is a powerful tool to exhaustively identify proteins in a complex
sample, but biochemistry of ECM proteins is particularly unfavorable to this method that need
significant adaptation to be effective with ECM samples. Finally, electron microscopy is the
ideal method to investigate the molecular and fibrillary organization of the ECM network.
2.1. Biochemistry of the main ECM components
2.1.1. Proteins and glycoproteins
A large diversity of proteins is found in ECMs where they are the principal component. They
are classified either in structural proteins that are directly involved in the overall architecture
of the ECM or in soluble factors that are globular proteins entrapped in the ECM network.
Structural proteins are mainly fibrous, insoluble, and high molecular weight molecules,
including collagens, elastin, laminins, and fibronectins. They are direct actors of the shape and
the mechanical properties of tissues and organs and further possess the ability to auto-
assemble among themselves as well as to interact with each other to form fibrillary network
and complex 3-D architectures. Most of the ECM proteins have sequences recognized by cells
for adhesions and some of them can bind specifically soluble growth factors or cytokines. These
molecules present several posttranslational modifications like hydroxylation at Proline and
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Lysine residues in collagens and O-glycosylation and N-glycosylation in laminins and
fibronectin.
Collagens are found in all types of ECMs and are the main constituent of connective tissues
like skin, bone, and tendons [3]. They belong to a large family of molecules with to date 28
members identified (numbered from collagen type I to type XXVIII). Collagens are trimeric
proteins, made of the association of three alpha-chains specific to each type of collagens that
assemble together to form a super-helix structure. For some collagen types several alpha-
chains exist, leading to multiple isoforms of the same collagen molecule and raising the
diversity and the complexity of the collagen family. In ECMs, collagens are organized in
different supramolecular assemblies inherited from the specificity for each collagen types
taking into account their amino-acid sequences and the 3-D folding of their tertiary structure
[4]. Fibril-forming collagens include collagen type I, II, III, V, and XI. They assemble in large
fibrils (up to 500 nm in diameter) that can merge to form collagen fibers of micrometric size.
All ECMs contain fibrillary collagens. Connective tissues are characterized by an abundant
ECM content made mainly by fibrils of collagen type I in dermis and bone, or of collagen type
II fibrils in cartilage. Basement membranes (BM) are a specialized form of ECM mainly found
in epithelial tissues and contain heterotypic fibrils combining collagen I and III or V [5]. Size
and diameters of collagen fibrils are regulated by other ECM molecules like fibril-associated
collagens or proteoglycans. Collagen fibrils and fibers are finally stabilized by covalent cross-
links making these structures highly resistant to mechanical load and stresses. Network-
forming collagens are mostly found in BM where collagen type IV is the most abundant.
Collagen IV molecules assemble in a hexameric superstructure that propagate to form finally
a 2-D network that is maintained by covalent crosslinks with methionine and lysine residues
[6].
Laminins are large molecular weight (from 400 to 900 kDa), heterotrimeric glycoproteins and,
along with collagen type IV, they are the main constituent of BM [7]. Even found in every BM,
laminin is a large family of molecules, and their distribution among BM is tissue-specific. A
laminin molecule consists of the association of one alpha, one beta, and one gamma chain. To
date, 5 alpha, 3 beta, and 3 gamma chains have been identified which may be assembled in 16
different laminin molecules. All laminins share common structural features: a cross-shaped 3-
D structure with one long and two shorts arms, di-sulfide bridges in-between the chains that
maintain their association and the presence of several N-glycosylation on asparagine residues.
Laminins auto-assemble in a network interlaced with the collagen type IV network. Directed
toward the cells, laminins gives cues for cell adhesions through integrin receptors.
Elastin is organized in fibers closely linked to fibrillar collagens where it gives the elasticity to
tissues and compensate the tensile strength of collagen fibers [8]. Elastin is secreted by cells as
a 60–70 kDa monomeric soluble precursor, tropoelastin, which contains intermittent hydro‐
phobic domains. Tropoelastin monomers auto-assemble to form elastin fibers that are stabi‐
lized by enzymatic cross-linking through Lysine residues and rendering the elastin network
highly insoluble. Stacks of hydrophobic domains in the elastin network are responsible for its
elastic properties and make elastin highly resistant to enzymatic degradation and solubiliza‐
tion in aqueous solutions.
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2.2.2. Immunohistochemistry of the extracellular matrix
IHC enables the identification of a specific component of the ECM and to image its distribution
within the tissue [25]. The target molecule is recognized by an antibody that reacts to a specific
epitope and then is visualized by light microscopy through a chromogenic enzymatic reaction
(alkaline phosphatase or horseradish peroxidase) or through a fluorescent dye with a fluores‐
cence microscope. The antibody is observed directly if the dye or the enzyme is linked to it,
but most of the time it is detected indirectly by a labeled (by a fluorophore or an enzyme)
secondary antibody which reacts to the first one through its Fc fragment. Frozen sections are
more appropriate for Immunohistochemistry because they avoid the use of fixative that may
alter the epitope, but frozen sections cannot be counterstained and so keeps the tissue organ‐
ization around the epitope not visible [26]. In contrast, FFPE samples are well preserved and
can be counterstained with different dyes after antibody incubation and detection. However,
if the fixative (generally 4% paraformaldehyde in neutral buffer) preserves the morphology of
the tissue, it can severely compromise the antigenicity of the target molecule, and then make
immunodetection inefficient or inoperative. Paraformaldehyde fixative triggers intra- and
intermolecular cross-linking of proteins by the formation of methylene bridges between amino
acids residues [25]. It may also alter the molecular structure of polysaccharides, lipids, and
nucleic acids. The degree of cross-linking will depend on the concentration and the pH of the
fixative solution, as well as on the time and the temperature at what the fixation is performed.
The formation of intra- and intermolecular cross-linking modifies the secondary and tertiary
structures of proteins that lower the detection by antibodies because of the modification of the
target epitopes [27]. In the early 1990s, an antigen retrieval (AR) method was introduced to
recover the antigenicity of FFPE tissue sections impaired by the fixation treatment [28]. The
AR method originally refers to the high-temperature processing of FFPE sections, but with the
development of other methods it is nowadays a generic term for any kind of treatment used
to recover the original antigenicity of the FFPE sections [29]. The rationale of AR is the breaking
of fixative-induced cross-links and methylene bridges that enable a renaturation of the proteins
and a partial recovery of the epitopes. However, it has to be noticed that the true mechanism
of AR is not yet understood, and it remains an empirical technique that requires several
positive and negative controls to avoid true- or false-positive reactions [30]. AR is performed
with the use of heat (called heat-induced antigen or epitope retrieval) or enzymes (referred-to
PIER for proteolytic enzyme-induced epitope retrieval) to break fixative cross-links.
In heat-Induced epitope retrieval (HIER), three parameters appear essential in the outcome of
the AR: temperature and pH of the solution and time of incubation of the sections [29,31].
Classically, sections are incubated for 10–20 minutes at 95°C in a water bath. Microwave and
steam-cookers are also used to heat sections and have shown good AR properties, although
the control of the temperature is more delicate. The pH of the solution is a critical factor because
some epitopes will be revealed only in acidic or in alkaline buffer. The most common acidic
buffer is citrate used in a pH range of 3–6. The most used alkaline buffer is Tris supplemented
or not with EDTA at pH 8–10 [29,31]. All pH, temperature, and time have to be checked
carefully because extreme conditions will damage the tissue sections.
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Enzyme treatment is thought to break some of the fixative methylene bridges and to elicit the
reconstitution of epitopes after a moderate digestion of proteins. It is generally performed with
proteolytic enzymes such as pepsin, trypsin and proteinase K at a concentration of 0.05–1%
for 10–30 minutes. Glycosidases, such as hyaluronidase, chondroitinase, and keratinase have
shown valuable AR properties on polysaccharides-rich tissues and on glycosylated proteins
[32]. The pH and temperature of the solution are adjusted to the optimal activity of the enzyme,
and time of digestion and the concentration of the enzyme have to be carefully set to avoid
overdigestion of the tissue sections which will lead to a loss of tissue structure and
organization.
Success of immunohistostaining mainly relies upon the quality of the antibody. Compared to
soluble proteins, only few antibodies against ECM molecules are commercially available [32].
The ECM proteins are highly conserved in mammals making difficult the immunization of
animals to generate an efficient antibody. Some antibodies are raised from synthetic peptides
(5–20 amino acids) chosen from the primary amino-acid sequence of the target protein, but the
epitope generated could be irrelevant to the secondary and tertiary structures of the native
proteins [33]. Polysaccharides are either not or very slightly immunogenic, making very
difficult to generate antibodies against the sugar part of proteoglycans. Moreover, ECM
proteins are organized into dense fibers structures or meshwork or bear high polysaccharides
chains that hinder the access of the antibody to the epitopes. In conclusion, IHC of the ECM is
a delicate technique but remains the best option to obtain a picture of individual ECM
components distribution within the different compartments of a tissue. As an example among
several ones, by the means of monoclonal antibodies raised against laminin chains alpha-4 and
-5, beta-1 and -2, and gamma-1, it has been possible to elucidate the particular composition
and organization of the basement membrane surrounding islets of Langerhans in human
pancreas [34]. The identification of a duplex BM surrounding intra-islets vessels with a specific
laminin composition for each of the two BM has led to the proposition of a double-basement
membrane model of human islets of Langerhans clearly distinct from the organization of
basement membrane surrounding islets in mouse [35].
2.3. Identification of ECM composition by proteomics with mass spectrometry
The proteomic strategy is based on the isolation of a complex mixture of proteins from cells,
tissues, or a whole organism and their identification by mass spectrometry and genomic
database. Mass spectrometers commonly used for protein identification are MALDI–TOF (for
Matrix–Assisted Lazer Desorption Ionization—Time of Flight) and ESI-Q-TOF (for Electro
Spray Ionization—Quadripole—Time of Flight) that have their own characteristics and
performances but do not change the general flow-chart of the sample preparation and
identification [36,37]. After extraction and purification, proteins are separated by 1D or 2D
sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE), respectively to
their molecular weight (1D) or by both their isoelectric point (pH which net charge of protein
is neutral) and molecular weight (2D). Mass spectrometers only detect charged molecules with
an accuracy and sensibility that depends on the ratio of mass over charge (m/z), so the proteins
samples have to be hydrolyzed into peptides before mass spectrometry analysis to obtain
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spectra at atomic resolution. Protein bands (1D) or spots (2D) are excised from the gel,
hydrolysed into peptides by a proteolytic enzyme (frequently Trypsin), and loaded in the mass
spectrometer to measure the exact mass of the peptides. Each protein from the original mixture
is identified by matching the measured masses of their peptides with the expected masses of
peptides calculated in silico from genomic database [37,38]. This technique allows a large-scale
identification of components without the bias of predetermined molecular candidates as with
antibody detection. It is thus possible in theory to have the exact protein composition of a tissue
and follow its modification with time or diseases [39].
The total or relative amount of identified proteins can also be addressed. The SDS-PAGE
migration pattern and intensity of protein band (1D) or spot (2D) give a “map” of the protein
content of the target tissue or organ and can be used to identify particular band/spot that are
modified in specific conditions, enabling discovery of new therapeutic targets [40]. Labeling
methods exist to generate quantitative data with mass spectrometry. Samples of the control
conditions are modified with nuclear isotopes 13C, 15N, or 18O, whereas the treated sample
is left unmodified, and the relative abundance of both isotopic pics is compared [41]. A direct
semiquantitative approach is also possible, with the mathematical integration of ion counts of
the peptides identifying each protein to describe its relative abundance [42]. In the ECM
analysis, relative quantification is a remarkable tool to identify the specific isoform of some
multimeric ECM proteins, such as collagens and laminins, as the relative amount of each
monomer will indicate under which form the ECM molecule is present in the tissue. To be
more specific, collagen type V exists in the common heterotrimeric isoform [α1(V)]2α2(V) and
a more scarce homotrimeric isoform [α1(V)]3. The relative amount of ion counts for the α1(V)
chain over α2(V) chain will indicate if the α1(V) chain is associated only with α2(V) (α1 chain
signal twofold of α2 chain signal) or if the investigated tissue contains both heterotrimeric
[α1(V)]2α2(V) and homotrimeric [α1(V)]3 isoforms (α1 chain signal >> twofold of α2 chain
signal). However, quantification by mass spectrometry can be restricted by the ionization
properties of some proteins that will make them less detected and consequently under-
represented in the final analysis. Nevertheless, this highlights the potentials of proteomics and
mass spectrometry in the study of ECM proteins, as such characterization of ECM proteins
isoform will require several antibodies (i.e., one per protein chain) to identify one isoform by
western blot or IHC [43].
The most critical steps of a proteomic analysis are the purification of the protein mixture and
their identification from database. ECM proteins have a high molecular weight and are tightly
associated with each other by covalent cross links that make them mostly insoluble. An
important point in the analysis of ECM by mass spectrometry proteomic will be the proper
solubilization of the ECM [44]. The tissue has to be first carefully decellularized to purify the
ECM and eliminate the remaining intracellular proteins. This step requires the use of a
detergent like SDS and will eliminate from the ECM part of the loosely bounded proteins like
remodeling enzymes or growth factors [40]. The purified ECM can be solubilized by a
combination of physical, chemical, and enzymatic methods. A physical method is the me‐
chanical breaking with a French press or grinding with mortar and pestle in liquid nitrogen.
This step is important to homogenize correctly the purified ECM and make the following
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solubilization treatment effective. Ultrasound can also be used, but this process yields heat
that can denaturate and break the proteins creating smears instead of protein bands or spots
during SDS-PAGE separation if temperature is not carefully controlled. Homogenized ECM
can be solubilized with a chaotropic agent like concentrated urea or guanidium chloride [45].
These molecules are efficient for solubilization, but a too high concentration is not compatible
with SDS-PAGE separation and can impair the trypsin digestion. Highly cross-linked collagen
fibrils or elastin microfibrils can remain insoluble after chaotropic extraction. Partial digestion
with proteolytic enzymes such as pepsin is also used to favor ECM solubilization, but again,
it has to be done carefully to not hydrolyze the ECM sample before SDS-PAGE separation.
Deglycosylation with glucosidase such as PNGase or chondroitinase can unravel parts of the
dense polysaccharide network of proteoglycan and unleash trapped ECM proteins [45].
Moreover, deglycosylation is also favorable for further trypsin digestion and peptide identi‐
fication from database. ECM proteins undergo several posttranslational modifications, such
as hydroxylation, disulfide bridges, and glycosylation that can block digestive sites for trypsin,
leading to inefficient peptide generation, or resulted in peptides of different masses than the
expected masses from the genomic data base, leading to inappropriate identification of the
protein. All these biochemical specificities of ECM proteins make proteomic discovery
challenging and explain why only a few proteome of ECMs have been published so far.
Nevertheless, this approach has a huge potential and consequently efficient solubilization and
identification protocols are under development to make this technique more routinely usable
in ECM and biomaterials characterization.
2.4. Three-dimensional organization of ECMs studied by electron microscopy
Electron microscopy gives higher spatial resolution than light microscopy with the use a
shorter wave-length from an electron beam. With resolution at the nanometres scale, and below
with high resolution microscopes, it gives access to the molecular structure of ECM proteins
and can image their supramolecular organization (i.e., fibrils and fibers assemblies) that are
hardly distinguishable with optical microscopes. Transmission electronic microscopes (TEM)
are built on the same scheme as optical/visible-light microscopes and so, equivalent techniques
and processing of samples are required for both type of microscopy. In TEM, the electron beam
pass through the samples to give rise to a projected image on an electron-sensitive surface like
a phosphorescent screen, on a silver-film plate to record the image or nowadays on CCD
cameras. The electron beam requires a vacuum pressure and cannot pass through thick
samples of several micrometers which both represent a challenge for biological samples that
are mainly wet, thick, and soft materials [46]. Biological tissues have to be fixed, dehydrated,
and embedded in hard material (epoxy resin) and sliced with a diamond knife ultra-microtome
into hundreds nanometres slices to be investigated by TEM. The electron beam interacts poorly
with low atomic numbers atoms, such as carbon, oxygen, and nitrogen found in biological
samples, so sections are stained with heavy metal solutions (commonly tungsten in phospho‐
tungstic acid, uranium in uranyl acetate, and lead in lead citrate) to give contrast [47]. Com‐
pared to histological staining, negative staining is more commonly used to prepare TEM
sample to improve the contrast of organic materials: heavy metals dyes are absorbed by the
background that creates contrast to the slightly stained specimen. The observation of ECM by
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TEM is nearly concomitant of its apparition in the late 1930s. Native collagen fibrils extracted
from tissues and stained negatively with phosphotungtsic acid present a typical cross-striated
pattern with a series of dark and light bands, spaced with a regular period of 67 nm. These
observations have allowed the establishment of the assembly model of collagen molecules into
collagen fibrils, known as the quarter-stagger model from Hodge and Petruska (1963). This
model proposes a lateral stacking of collagen molecules, creating overlaps that exclude
phosphotungstic dye and appear light, and a longitudinal collinear succession of collagen
molecule spaced with a constant gap filled by Tungsten dye and appears dark under electron
beam [48]. The cross-striated pattern is characteristic of fibrillary collagen, that are collagen
type I, type II, and type III. On the other hand, network forming collagen type IV do not present
any bands on TEM but is seen as a meshwork of hexagonal structures [49]. The resolution
(roughly 1–5 nm) of TEM allows analyzing single macromolecules deposited on carbon film
and stained by rotary-shadowing, creating a 3D electron sensitive replica of the specimen [50].
This method has revealed the semiflexible rod structure of collagen molecules terminated by
a globular C-term pro-peptide and the cross-shaped triple chain structure of laminin mole‐
cules. TEM is particularly accurate to measure length of ECM molecules and diameters of fibrils
and fibers assembly. These last parameters are important when analyzing a tissue because
ECM fibrils diameters appear to be tissue-specific and modification of their size can be induced
by pathologies such as diabetes, fibrosis, cancer, or aging and consequently impair tissue
organization and function [51]. Compact bone tissue which supports most of the load of the
body and muscles anchorage has to resist strong mechanical solicitations, but it is surprisingly
light in weight structure if compared to human-engineered buildings. Bone tissue is made of
an abundant organic ECM, strengthened with a mineral phase, and has highly hierarchical
structure with length scales ranging from meters to nanometers that give its overall mechanical
properties [52]. The shaft of long bones is organized in cylindrical osteons formed by successive
concentric lamellae, themselves constituted by compact assemblies of collagen fibrils. An
oblique transverse section of successive concentric lamellae made with ultra-microtome and
observed with TEM revealed coexistence of two patterns of organization for collagen fibrils
[53]. One is an alternation of parallel and orthogonal fibrils, with a regular 90° shift of fibrils
orientation from one lamellae to another. The second is seen under TEM as arced structures,
as if collagen fibrils were bent in between two series of longitudinal fibrils. The arced pattern
is the consequence of the oblique sections into succession of collagen fibrils rotating with a tiny
and constant angle from one lamellae to another, creating the illusion of bend structures [54].
From these TEM observations, a twisted plywood model of collagen fibril organization in bone
has been proposed. This particular constant angle twist recall the organization observed in
some liquid crystal phase, and it has been suggested that collagen molecules could have a
liquid crystal behavior and autoassemble in higher-scales structures [21,55]. This finally
underlines the potentials of transmission electron microscopy (TEM) to address ECM archi‐
tectures in tissues. As mentioned above, similar techniques and processing of samples used in
optical microscopy are also applied with TEM. The different components of the ECM can be
identified by immunolabeling with the same limitations for the necessity to retrieve antigens
from the fixation and embedding processes. The antibodies are covalently linked to a gold
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particle to be seen by TEM and multiple labeling is possible with the use of a specific size of
gold particle for each antibody [30].
TEM, however, needs a very thin specimen and cannot directly image a 3D structure. Unlike
TEM, scanning electron microscope (SEM) uses electrons reflected from the surface of the
sample as signals for image generation and provides information on surface topography,
fibrillar organization, porosity, and also atomic composition of a bulk sample [56]. Samples
have to be dehydrated to enter the low-vacuum chamber of the microscope and coated with
an electron conducting layer (commonly gold) to ensure an adequate contrast and avoid
charging phenomenon on the sample which are deleterious for the quality of the image. To
keep their native 3D structure intact, biological samples are usually dehydrated by ethanol
treatment and to a critical point drying. This procedure has enabled the evaluation of collagen
fibrils diameters and spatial organization in reconstituted collagen hydrogels [57]. In biological
tissues, the higher proportion of cells compared to ECM can minimize the access to the ECM
fibrillar network. By a gentle decellularization method, the cellular counterpart of the tissue
is removed and the native ECM frame remains [58]. This process mainly keeps in their original
shape the reticular fibers of collagen and elastin but degrade most part of the laminins and
GAGs network.
3. Extracellular matrix-inspired biomaterials
The deep exploration of ECMs composition, organization, and biological functions associated
with the development of methods to produce new biocompatible materials has enabled
material scientists to recreate ex vivo some of the key characteristics of ECM [59]. This section
focuses on how the structural and functional characteristics derived from the knowledge of
the native cell microenvironment have been applied to design biologically relevant biomate‐
rials. Different strategies currently exist to build 3D models of the ECM: tissue-derived ECM,
use of natural or synthetic polymers, and formulation into hydrogel or porous 3D materials.
Some biomaterials are designed to recreate the composition of the ECM and thus offering the
right environment for studying cell adhesion and anchorage-associated cell phenotypes. Other
materials are developed to recreate the 3D architectures of ECM, proposing fibrillary structures
with similar organization and mechanical properties of native tissues. These examples
represent preliminary attempts of ex vivo models of ECM that will most likely be improved
and increase with an overcoming of technical hurdle faced by material scientists and with
rising interest of cell biologists for 3D models that will ask for more refined and specific
materials to answer fundamental questions on cell biology.
3.1. Strategies to engineer 3D models of ECMs
3.1.1. Tissue-derived ECM: the gold standard Matrigel®
A basement membrane-derived tissue isolated from Engelberth–Holm–Swarm (EHS) mouse
sarcoma is commercially available under the brand name Matrigel® (BD Biosciences) and has
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On 2D surfaces, it has been shown that cells are responsive to surface rigidity and that it
influences the commitment of mesenchymal stem cells toward differentiation in a specific
lineage [96]. Again, surface stiffness applies forces which are unevenly distributed on the cells
(i.e., only located at the cell-surface interface). Developing a 3D material with tuned and
controllable mechanical properties will generate a more biologically relevant environment to
evaluate the role of ECM mechanobiology on cells functions and differentiation processes. To
study the influence of mechanical stiffness on mesenchymal stem cells differentiation, a series
of alginate gels with elastic modulus ranging from 2.5 to 110 kPa has been developed [97].
Mechanical properties of alginate gels are modulated by the percentage of alginate polymers
in the final hydrogel. Because alginate is not sensitive to the degradation of hydrolytic enzymes
of mammalian cells, the elastic modulus of the mechanical properties of the material are
expected to remain constant all along the study (7 days of cell culture). RGD-peptides are
covalently grafted to alginate polymers prior to hydrogel formation to give to the cells adhesive
cues. The more rigid materials trigger mesenchymal stem cells differentiation toward bone
lineage with an expression of the bone-related molecular markers such as alkaline phosphatase
and osteopontin after 7 days of culture. On the other hand, alginate gels with the lower elastic
modulus (softer material) triggers an accumulation of oil-droplets into stem cells, indicating
adipose tissue differentiation. The density of RGD-peptides incorporated into these materials
did not modify the cell fate related to the elastic modulus of the material, but induce a higher
level of expression of the lineage markers for both bone and adipose-committed cells.
3.4. Conclusion: toward a gold-standard of 3D model of ECMs?
As mentioned at the beginning of this section, the ECM-derived Matrigel® represents currently
the most often used material for 3D experiments in cell biology. Despite that Matrigel®-related
drawbacks are of importance, Matrigel®is a widely and available model to investigate many
fundamental questions in cell biology, from cell adhesion and tumor formation, to drug testing.
We have presented in this chapter a large panel of techniques, methodologies, and engineering
processes that allow the exploration of ECM organization and permit to recreate ex vivo some
of their key features. At the conclusion of this chapter and after the review of several studies
investigating various 3D materials, it appears that no material can represent the unique and
ideal answer for all cell investigations in 3D [63]. A modular approach should be taken by
rationalizing the biological question to be studied and the parameter of ECM intended to be
recreated. Nevertheless, more and more complex materials are engineered that will finally be
able to mimic simultaneously several key factors of ECM composition, architecture, or
mechanical properties, and so enabling investigation of multiple parameters for cell biology
experiments. An important drawback with engineered 3D materials is to create a “black-box”
where undefined and uncontrollable parameters may influence the cellular outcomes to be
investigated. To avoid part of this problem, rigorous attention should be paid on the purity of
polymers used to build the material, in particular with biological polymers. The development
of DNA-recombinant production of ECM proteins can overcome this problem, even if this will
raise ultimately the cost of the final material. The structural characteristics of the final material
(porosity, polymers distribution, and fibrils diameter) should be consistently reproducible and
addressed. To do so, an “easy,” meaning straightforward, process of the material should be
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sought and preferred rather than a more complex multistep fabrication process. Biomaterial
scientists propose continuously new design and approaches to engineer ex vivo ECMs. The
production of a gold-standard material may become possible for a specific biological question.
It might happen with the existence of a deep and intelligible dialog in-between material
scientists, whom brings engineering strategies, and the cell biologists, that implement the
material design to mimic the biological process that has to be investigated ex vivo. This
collaboration may result in major advances for science and medicine.
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